Cargando…
Natural Radiosensitizers in Radiotherapy: Cancer Treatment by Combining Ionizing Radiation with Resveratrol
Conventional cancer treatment is mainly based on the surgical removal of the tumor followed by radiotherapy and/or chemotherapy. When surgical removal is not possible, radiotherapy and, less often, chemotherapy is the only way to treat patients. However, despite significant progress in understanding...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501384/ https://www.ncbi.nlm.nih.gov/pubmed/36142554 http://dx.doi.org/10.3390/ijms231810627 |
_version_ | 1784795461347966976 |
---|---|
author | Komorowska, Dominika Radzik, Tomasz Kalenik, Sebastian Rodacka, Aleksandra |
author_facet | Komorowska, Dominika Radzik, Tomasz Kalenik, Sebastian Rodacka, Aleksandra |
author_sort | Komorowska, Dominika |
collection | PubMed |
description | Conventional cancer treatment is mainly based on the surgical removal of the tumor followed by radiotherapy and/or chemotherapy. When surgical removal is not possible, radiotherapy and, less often, chemotherapy is the only way to treat patients. However, despite significant progress in understanding the molecular mechanisms of carcinogenesis and developments in modern radiotherapy techniques, radiotherapy (alone or in combination) does not always guarantee treatment success. One of the main causes is the radioresistance of cancer cells. Increasing the radiosensitivity of cancer cells improves the processes leading to their elimination during radiotherapy and prolonging the survival of cancer patients. In order to enhance the effect of radiotherapy in the treatment of radioresistant neoplasms, radiosensitizers are used. In clinical practice, synthetic radiosensitizers are commonly applied, but scientists have recently focused on using natural products (phytocompounds) as adjuvants in radiotherapy. In this review article, we only discuss naturally occurring radiosensitizers currently in clinical trials (paclitaxel, curcumin, genistein, and papaverine) and those whose radiation sensitizing effects, such as resveratrol, have been repeatedly confirmed by many independent studies. |
format | Online Article Text |
id | pubmed-9501384 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-95013842022-09-24 Natural Radiosensitizers in Radiotherapy: Cancer Treatment by Combining Ionizing Radiation with Resveratrol Komorowska, Dominika Radzik, Tomasz Kalenik, Sebastian Rodacka, Aleksandra Int J Mol Sci Review Conventional cancer treatment is mainly based on the surgical removal of the tumor followed by radiotherapy and/or chemotherapy. When surgical removal is not possible, radiotherapy and, less often, chemotherapy is the only way to treat patients. However, despite significant progress in understanding the molecular mechanisms of carcinogenesis and developments in modern radiotherapy techniques, radiotherapy (alone or in combination) does not always guarantee treatment success. One of the main causes is the radioresistance of cancer cells. Increasing the radiosensitivity of cancer cells improves the processes leading to their elimination during radiotherapy and prolonging the survival of cancer patients. In order to enhance the effect of radiotherapy in the treatment of radioresistant neoplasms, radiosensitizers are used. In clinical practice, synthetic radiosensitizers are commonly applied, but scientists have recently focused on using natural products (phytocompounds) as adjuvants in radiotherapy. In this review article, we only discuss naturally occurring radiosensitizers currently in clinical trials (paclitaxel, curcumin, genistein, and papaverine) and those whose radiation sensitizing effects, such as resveratrol, have been repeatedly confirmed by many independent studies. MDPI 2022-09-13 /pmc/articles/PMC9501384/ /pubmed/36142554 http://dx.doi.org/10.3390/ijms231810627 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Komorowska, Dominika Radzik, Tomasz Kalenik, Sebastian Rodacka, Aleksandra Natural Radiosensitizers in Radiotherapy: Cancer Treatment by Combining Ionizing Radiation with Resveratrol |
title | Natural Radiosensitizers in Radiotherapy: Cancer Treatment by Combining Ionizing Radiation with Resveratrol |
title_full | Natural Radiosensitizers in Radiotherapy: Cancer Treatment by Combining Ionizing Radiation with Resveratrol |
title_fullStr | Natural Radiosensitizers in Radiotherapy: Cancer Treatment by Combining Ionizing Radiation with Resveratrol |
title_full_unstemmed | Natural Radiosensitizers in Radiotherapy: Cancer Treatment by Combining Ionizing Radiation with Resveratrol |
title_short | Natural Radiosensitizers in Radiotherapy: Cancer Treatment by Combining Ionizing Radiation with Resveratrol |
title_sort | natural radiosensitizers in radiotherapy: cancer treatment by combining ionizing radiation with resveratrol |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501384/ https://www.ncbi.nlm.nih.gov/pubmed/36142554 http://dx.doi.org/10.3390/ijms231810627 |
work_keys_str_mv | AT komorowskadominika naturalradiosensitizersinradiotherapycancertreatmentbycombiningionizingradiationwithresveratrol AT radziktomasz naturalradiosensitizersinradiotherapycancertreatmentbycombiningionizingradiationwithresveratrol AT kaleniksebastian naturalradiosensitizersinradiotherapycancertreatmentbycombiningionizingradiationwithresveratrol AT rodackaaleksandra naturalradiosensitizersinradiotherapycancertreatmentbycombiningionizingradiationwithresveratrol |